Table 1

Clinical characteristics of study patients with multiple sclerosis (N=598).

Variablesn(%)
Gender
 Male214(35.8)
 Female384(64.2)
Marital status
 Single250(41.8)
 Married310(51.8)
 Divorced36(6)
 Widower2(0.4)
Education level
 Illiterate4(0.7)
 Primary12(2)
 Intermediate28(4.7)
 Secondary140(23.4)
 University378(63.2)
 Postgraduate36(6)
Regions
 Southern170(28.4)
 Middle150(25.1)
 East114(19.1)
 North28(4.7)
 West136(22.7)
Age (years), mean±SD [range]32.4±8.4[15-60]
At disease onset, mean±SD [range]26.9±7.6[13-56]
Disease duration (years), mean±SD6.5±4.7
Number of admission, mean±SD1.4±1.7
Number of attacks during last 2 years), mean±SD [range]1.4±1.9[0-14]
Drug used now (n=558)
Interferon beta-1b (Betaferon)146(26.2)
Interferon beta-1a (Rebif)114(20.5)
Interferon beta-1a (Avonex)100(17.9)
Teriflunomide (Aubagio)20(3.6)
Dimethyl fumarate (Tecfidera)18(3.2)
Fingolimod (Gilenya)108(19.3)
Natalizumab (Tysabri)46(8.2)
Rituximab (Rituxan)4(0.7)
Alemtuzumab (Lemetrada)2(0.5)